By Michael Bloom
Publication Date: 2026-05-26 12:16:00
Here are Tuesday’s biggest calls on Wall Street: UBS upgrades Vipshop to buy from neutral UBS said the Chinese e-commerce company has earnings resilience. “Amid still muted consumption and intense e-commerce competition, we think Vipshop’s (VIPS) near-term growth will remain under pressure. However, we flag more attractive earnings quality and shareholder returns.” JPMorgan initiates Seaport Therapeutics as overweight JPMorgan said it’s bullish on the biotech company. “We are initiating coverage of Seaport Therapeutics, Inc. (Seaport; SPTX) with an Overweight rating and a Dec 2027 price target of $42.” Citi initiates Pershing Square as buy Citi said the stock has some of the “best attributes” for an asset manager. “We are initiating coverage of Pershing Square with a Buy/High Risk rating and $50 price target.” Read more. Stifel upgrades Booz Allen Hamilton to buy from hold Stifel said the stock too attractive to ignore. “Fundamentals are slowly improving, the stock is beaten down, and evidence suggests the risk of guidance cuts are in the rearview mirror. While BAH’s FQ4 2026 earnings (ended March 31, 2026) were not too consequential (revenue slightly below estimates but higher margin), our upgrade is anchored on low valuation and low expectations.” JPMorgan upgrades Cognex, Timken and Allient to overweight from neutral JPMorgan upgraded the three stocks and said they have positive exposure to robotics and humanoids. “We are upgrading Allient ( ALNT), Cognex ( CGNX), and…